- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The OTC Anti-Infective Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global OTC Anti-Infective Products market size is estimated to be worth US$ 13710 million in 2021 and is forecast to a readjusted size of USD 17150 million by 2028 with a CAGR of 3.3% during review period. Hospital Pharmacies accounting for % of the OTC Anti-Infective Products global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Antifungal segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of OTC Anti-Infective Products include Bayer, GSK, Teva, Johnson & Johnson, and NOVARTIS, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
OTC Anti-Infective Products market is split by Type and by Sales Channel. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Sales Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Antifungal
Antibacterial
Antiviral
Antiseptics
Others
Market segment by Sales Channel can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The key market players for global OTC Anti-Infective Products market are listed below:
Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe OTC Anti-Infective Products product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of OTC Anti-Infective Products, with price, sales, revenue and global market share of OTC Anti-Infective Products from 2019 to 2022.
Chapter 3, the OTC Anti-Infective Products competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the OTC Anti-Infective Products breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, sales channel, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and OTC Anti-Infective Products market forecast, by regions, type and sales channel, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of OTC Anti-Infective Products.
Chapter 13, 14, and 15, to describe OTC Anti-Infective Products sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 OTC Anti-Infective Products Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global OTC Anti-Infective Products Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Antifungal
1.2.3 Antibacterial
1.2.4 Antiviral
1.2.5 Antiseptics
1.2.6 Others
1.3 Market Analysis by Sales Channel
1.3.1 Overview: Global OTC Anti-Infective Products Revenue by Sales Channel: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global OTC Anti-Infective Products Market Size & Forecast
1.4.1 Global OTC Anti-Infective Products Sales in Value (2017 & 2021 & 2028)
1.4.2 Global OTC Anti-Infective Products Sales in Volume (2017-2028)
1.4.3 Global OTC Anti-Infective Products Price (2017-2028)
1.5 Global OTC Anti-Infective Products Production Capacity Analysis
1.5.1 Global OTC Anti-Infective Products Total Production Capacity (2017-2028)
1.5.2 Global OTC Anti-Infective Products Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 OTC Anti-Infective Products Market Drivers
1.6.2 OTC Anti-Infective Products Market Restraints
1.6.3 OTC Anti-Infective Products Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer OTC Anti-Infective Products Product and Services
2.1.4 Bayer OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK OTC Anti-Infective Products Product and Services
2.2.4 GSK OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva OTC Anti-Infective Products Product and Services
2.3.4 Teva OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson OTC Anti-Infective Products Product and Services
2.4.4 Johnson & Johnson OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 NOVARTIS
2.5.1 NOVARTIS Details
2.5.2 NOVARTIS Major Business
2.5.3 NOVARTIS OTC Anti-Infective Products Product and Services
2.5.4 NOVARTIS OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 MYLAN
2.6.1 MYLAN Details
2.6.2 MYLAN Major Business
2.6.3 MYLAN OTC Anti-Infective Products Product and Services
2.6.4 MYLAN OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sun Pharma
2.7.1 Sun Pharma Details
2.7.2 Sun Pharma Major Business
2.7.3 Sun Pharma OTC Anti-Infective Products Product and Services
2.7.4 Sun Pharma OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CR SANJIU
2.8.1 CR SANJIU Details
2.8.2 CR SANJIU Major Business
2.8.3 CR SANJIU OTC Anti-Infective Products Product and Services
2.8.4 CR SANJIU OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Cipla
2.9.1 Cipla Details
2.9.2 Cipla Major Business
2.9.3 Cipla OTC Anti-Infective Products Product and Services
2.9.4 Cipla OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Lingrui
2.10.1 Lingrui Details
2.10.2 Lingrui Major Business
2.10.3 Lingrui OTC Anti-Infective Products Product and Services
2.10.4 Lingrui OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 OTC Anti-Infective Products Breakdown Data by Manufacturer
3.1 Global OTC Anti-Infective Products Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global OTC Anti-Infective Products Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in OTC Anti-Infective Products
3.4 Market Concentration Rate
3.4.1 Top 3 OTC Anti-Infective Products Manufacturer Market Share in 2021
3.4.2 Top 6 OTC Anti-Infective Products Manufacturer Market Share in 2021
3.5 Global OTC Anti-Infective Products Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and OTC Anti-Infective Products Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global OTC Anti-Infective Products Market Size by Region
4.1.1 Global OTC Anti-Infective Products Sales in Volume by Region (2017-2028)
4.1.2 Global OTC Anti-Infective Products Revenue by Region (2017-2028)
4.2 North America OTC Anti-Infective Products Revenue (2017-2028)
4.3 Europe OTC Anti-Infective Products Revenue (2017-2028)
4.4 Asia-Pacific OTC Anti-Infective Products Revenue (2017-2028)
4.5 South America OTC Anti-Infective Products Revenue (2017-2028)
4.6 Middle East and Africa OTC Anti-Infective Products Revenue (2017-2028)
5 Market Segment by Type
5.1 Global OTC Anti-Infective Products Sales in Volume by Type (2017-2028)
5.2 Global OTC Anti-Infective Products Revenue by Type (2017-2028)
5.3 Global OTC Anti-Infective Products Price by Type (2017-2028)
6 Market Segment by Sales Channel
6.1 Global OTC Anti-Infective Products Sales in Volume by Sales Channel (2017-2028)
6.2 Global OTC Anti-Infective Products Revenue by Sales Channel (2017-2028)
6.3 Global OTC Anti-Infective Products Price by Sales Channel (2017-2028)
7 North America by Country, by Type, and by Sales Channel
7.1 North America OTC Anti-Infective Products Sales by Type (2017-2028)
7.2 North America OTC Anti-Infective Products Sales by Sales Channel (2017-2028)
7.3 North America OTC Anti-Infective Products Market Size by Country
7.3.1 North America OTC Anti-Infective Products Sales in Volume by Country (2017-2028)
7.3.2 North America OTC Anti-Infective Products Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Sales Channel
8.1 Europe OTC Anti-Infective Products Sales by Type (2017-2028)
8.2 Europe OTC Anti-Infective Products Sales by Sales Channel (2017-2028)
8.3 Europe OTC Anti-Infective Products Market Size by Country
8.3.1 Europe OTC Anti-Infective Products Sales in Volume by Country (2017-2028)
8.3.2 Europe OTC Anti-Infective Products Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Sales Channel
9.1 Asia-Pacific OTC Anti-Infective Products Sales by Type (2017-2028)
9.2 Asia-Pacific OTC Anti-Infective Products Sales by Sales Channel (2017-2028)
9.3 Asia-Pacific OTC Anti-Infective Products Market Size by Region
9.3.1 Asia-Pacific OTC Anti-Infective Products Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific OTC Anti-Infective Products Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Sales Channel
10.1 South America OTC Anti-Infective Products Sales by Type (2017-2028)
10.2 South America OTC Anti-Infective Products Sales by Sales Channel (2017-2028)
10.3 South America OTC Anti-Infective Products Market Size by Country
10.3.1 South America OTC Anti-Infective Products Sales in Volume by Country (2017-2028)
10.3.2 South America OTC Anti-Infective Products Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Sales Channel
11.1 Middle East & Africa OTC Anti-Infective Products Sales by Type (2017-2028)
11.2 Middle East & Africa OTC Anti-Infective Products Sales by Sales Channel (2017-2028)
11.3 Middle East & Africa OTC Anti-Infective Products Market Size by Country
11.3.1 Middle East & Africa OTC Anti-Infective Products Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa OTC Anti-Infective Products Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of OTC Anti-Infective Products and Key Manufacturers
12.2 Manufacturing Costs Percentage of OTC Anti-Infective Products
12.3 OTC Anti-Infective Products Production Process
12.4 OTC Anti-Infective Products Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 OTC Anti-Infective Products Typical Distributors
13.3 OTC Anti-Infective Products Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global OTC Anti-Infective Products Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global OTC Anti-Infective Products Revenue by Sales Channel, (USD Million), 2017 & 2021 & 2028
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer OTC Anti-Infective Products Product and Services
Table 6. Bayer OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK OTC Anti-Infective Products Product and Services
Table 10. GSK OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Teva Basic Information, Manufacturing Base and Competitors
Table 12. Teva Major Business
Table 13. Teva OTC Anti-Infective Products Product and Services
Table 14. Teva OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson OTC Anti-Infective Products Product and Services
Table 18. Johnson & Johnson OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. NOVARTIS Basic Information, Manufacturing Base and Competitors
Table 20. NOVARTIS Major Business
Table 21. NOVARTIS OTC Anti-Infective Products Product and Services
Table 22. NOVARTIS OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. MYLAN Basic Information, Manufacturing Base and Competitors
Table 24. MYLAN Major Business
Table 25. MYLAN OTC Anti-Infective Products Product and Services
Table 26. MYLAN OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 28. Sun Pharma Major Business
Table 29. Sun Pharma OTC Anti-Infective Products Product and Services
Table 30. Sun Pharma OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. CR SANJIU Basic Information, Manufacturing Base and Competitors
Table 32. CR SANJIU Major Business
Table 33. CR SANJIU OTC Anti-Infective Products Product and Services
Table 34. CR SANJIU OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Cipla Basic Information, Manufacturing Base and Competitors
Table 36. Cipla Major Business
Table 37. Cipla OTC Anti-Infective Products Product and Services
Table 38. Cipla OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Lingrui Basic Information, Manufacturing Base and Competitors
Table 40. Lingrui Major Business
Table 41. Lingrui OTC Anti-Infective Products Product and Services
Table 42. Lingrui OTC Anti-Infective Products Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global OTC Anti-Infective Products Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Units)
Table 44. Global OTC Anti-Infective Products Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in OTC Anti-Infective Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global OTC Anti-Infective Products Production Capacity by Company, (M Units): 2020 VS 2021
Table 47. Head Office and OTC Anti-Infective Products Production Site of Key Manufacturer
Table 48. OTC Anti-Infective Products New Entrant and Capacity Expansion Plans
Table 49. OTC Anti-Infective Products Mergers & Acquisitions in the Past Five Years
Table 50. Global OTC Anti-Infective Products Sales by Region (2017-2022) & (M Units)
Table 51. Global OTC Anti-Infective Products Sales by Region (2023-2028) & (M Units)
Table 52. Global OTC Anti-Infective Products Revenue by Region (2017-2022) & (USD Million)
Table 53. Global OTC Anti-Infective Products Revenue by Region (2023-2028) & (USD Million)
Table 54. Global OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 55. Global OTC Anti-Infective Products Sales by Type (2023-2028) & (M Units)
Table 56. Global OTC Anti-Infective Products Revenue by Type (2017-2022) & (USD Million)
Table 57. Global OTC Anti-Infective Products Revenue by Type (2023-2028) & (USD Million)
Table 58. Global OTC Anti-Infective Products Price by Type (2017-2022) & (US$/Unit)
Table 59. Global OTC Anti-Infective Products Price by Type (2023-2028) & (US$/Unit)
Table 60. Global OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 61. Global OTC Anti-Infective Products Sales by Sales Channel (2023-2028) & (M Units)
Table 62. Global OTC Anti-Infective Products Revenue by Sales Channel (2017-2022) & (USD Million)
Table 63. Global OTC Anti-Infective Products Revenue by Sales Channel (2023-2028) & (USD Million)
Table 64. Global OTC Anti-Infective Products Price by Sales Channel (2017-2022) & (US$/Unit)
Table 65. Global OTC Anti-Infective Products Price by Sales Channel (2023-2028) & (US$/Unit)
Table 66. North America OTC Anti-Infective Products Sales by Country (2017-2022) & (M Units)
Table 67. North America OTC Anti-Infective Products Sales by Country (2023-2028) & (M Units)
Table 68. North America OTC Anti-Infective Products Revenue by Country (2017-2022) & (USD Million)
Table 69. North America OTC Anti-Infective Products Revenue by Country (2023-2028) & (USD Million)
Table 70. North America OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 71. North America OTC Anti-Infective Products Sales by Type (2023-2028) & (M Units)
Table 72. North America OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 73. North America OTC Anti-Infective Products Sales by Sales Channel (2023-2028) & (M Units)
Table 74. Europe OTC Anti-Infective Products Sales by Country (2017-2022) & (M Units)
Table 75. Europe OTC Anti-Infective Products Sales by Country (2023-2028) & (M Units)
Table 76. Europe OTC Anti-Infective Products Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe OTC Anti-Infective Products Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 79. Europe OTC Anti-Infective Products Sales by Type (2023-2028) & (M Units)
Table 80. Europe OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 81. Europe OTC Anti-Infective Products Sales by Sales Channel (2023-2028) & (M Units)
Table 82. Asia-Pacific OTC Anti-Infective Products Sales by Region (2017-2022) & (M Units)
Table 83. Asia-Pacific OTC Anti-Infective Products Sales by Region (2023-2028) & (M Units)
Table 84. Asia-Pacific OTC Anti-Infective Products Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific OTC Anti-Infective Products Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 87. Asia-Pacific OTC Anti-Infective Products Sales by Type (2023-2028) & (M Units)
Table 88. Asia-Pacific OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 89. Asia-Pacific OTC Anti-Infective Products Sales by Sales Channel (2023-2028) & (M Units)
Table 90. South America OTC Anti-Infective Products Sales by Country (2017-2022) & (M Units)
Table 91. South America OTC Anti-Infective Products Sales by Country (2023-2028) & (M Units)
Table 92. South America OTC Anti-Infective Products Revenue by Country (2017-2022) & (USD Million)
Table 93. South America OTC Anti-Infective Products Revenue by Country (2023-2028) & (USD Million)
Table 94. South America OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 95. South America OTC Anti-Infective Products Sales by Type (2023-2028) & (M Units)
Table 96. South America OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 97. South America OTC Anti-Infective Products Sales by Sales Channel (2023-2028) & (M Units)
Table 98. Middle East & Africa OTC Anti-Infective Products Sales by Region (2017-2022) & (M Units)
Table 99. Middle East & Africa OTC Anti-Infective Products Sales by Region (2023-2028) & (M Units)
Table 100. Middle East & Africa OTC Anti-Infective Products Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa OTC Anti-Infective Products Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 103. Middle East & Africa OTC Anti-Infective Products Sales by Type (2023-2028) & (M Units)
Table 104. Middle East & Africa OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 105. Middle East & Africa OTC Anti-Infective Products Sales by Sales Channel (2023-2028) & (M Units)
Table 106. OTC Anti-Infective Products Raw Material
Table 107. Key Manufacturers of OTC Anti-Infective Products Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. OTC Anti-Infective Products Typical Distributors
Table 111. OTC Anti-Infective Products Typical Customers
List of Figures
Figure 1. OTC Anti-Infective Products Picture
Figure 2. Global OTC Anti-Infective Products Revenue Market Share by Type in 2021
Figure 3. Antifungal
Figure 4. Antibacterial
Figure 5. Antiviral
Figure 6. Antiseptics
Figure 7. Others
Figure 8. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel in 2021
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global OTC Anti-Infective Products Revenue, (USD Million) & (M Units): 2017 & 2021 & 2028
Figure 13. Global OTC Anti-Infective Products Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global OTC Anti-Infective Products Sales (2017-2028) & (M Units)
Figure 15. Global OTC Anti-Infective Products Price (2017-2028) & (US$/Unit)
Figure 16. Global OTC Anti-Infective Products Production Capacity (2017-2028) & (M Units)
Figure 17. Global OTC Anti-Infective Products Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. OTC Anti-Infective Products Market Drivers
Figure 19. OTC Anti-Infective Products Market Restraints
Figure 20. OTC Anti-Infective Products Market Trends
Figure 21. Global OTC Anti-Infective Products Sales Market Share by Manufacturer in 2021
Figure 22. Global OTC Anti-Infective Products Revenue Market Share by Manufacturer in 2021
Figure 23. OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 OTC Anti-Infective Products Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 OTC Anti-Infective Products Manufacturer (Revenue) Market Share in 2021
Figure 26. Global OTC Anti-Infective Products Sales Market Share by Region (2017-2028)
Figure 27. Global OTC Anti-Infective Products Revenue Market Share by Region (2017-2028)
Figure 28. North America OTC Anti-Infective Products Revenue (2017-2028) & (USD Million)
Figure 29. Europe OTC Anti-Infective Products Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific OTC Anti-Infective Products Revenue (2017-2028) & (USD Million)
Figure 31. South America OTC Anti-Infective Products Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa OTC Anti-Infective Products Revenue (2017-2028) & (USD Million)
Figure 33. Global OTC Anti-Infective Products Sales Market Share by Type (2017-2028)
Figure 34. Global OTC Anti-Infective Products Revenue Market Share by Type (2017-2028)
Figure 35. Global OTC Anti-Infective Products Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2028)
Figure 37. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2017-2028)
Figure 38. Global OTC Anti-Infective Products Price by Sales Channel (2017-2028) & (US$/Unit)
Figure 39. North America OTC Anti-Infective Products Sales Market Share by Type (2017-2028)
Figure 40. North America OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2028)
Figure 41. North America OTC Anti-Infective Products Sales Market Share by Country (2017-2028)
Figure 42. North America OTC Anti-Infective Products Revenue Market Share by Country (2017-2028)
Figure 43. United States OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe OTC Anti-Infective Products Sales Market Share by Type (2017-2028)
Figure 47. Europe OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2028)
Figure 48. Europe OTC Anti-Infective Products Sales Market Share by Country (2017-2028)
Figure 49. Europe OTC Anti-Infective Products Revenue Market Share by Country (2017-2028)
Figure 50. Germany OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific OTC Anti-Infective Products Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2028)
Figure 57. Asia-Pacific OTC Anti-Infective Products Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific OTC Anti-Infective Products Revenue Market Share by Region (2017-2028)
Figure 59. China OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America OTC Anti-Infective Products Sales Market Share by Type (2017-2028)
Figure 66. South America OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2028)
Figure 67. South America OTC Anti-Infective Products Sales Market Share by Country (2017-2028)
Figure 68. South America OTC Anti-Infective Products Revenue Market Share by Country (2017-2028)
Figure 69. Brazil OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2028)
Figure 73. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa OTC Anti-Infective Products Revenue Market Share by Region (2017-2028)
Figure 75. Turkey OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa OTC Anti-Infective Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of OTC Anti-Infective Products in 2021
Figure 80. Manufacturing Process Analysis of OTC Anti-Infective Products
Figure 81. OTC Anti-Infective Products Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
